EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

A randomized prospective study to assess the role of topical tacrolimus as preventive therapy in unstable acral vitiligo

Deepak Kumar, Vishal Thakur iD, Kiruthika Subburaj iD, Anuradha Bishnoi iD, Keshavamurthy Vinay iD, Muthu Sendhil Kumaran iD, Davinder Parsad iD

Journal of the European Academy of Dermatology and Venereology · 2023

DOI: 10.1111/jdv.19362 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2023. Verfasst von Deepak Kumar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology, and Leprology, Post Graduate Institute of Medical Education and Research, Chandigarh, India. Hauptthemen laut MEDLINE: Tacrolimus, Vitiligo. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acral vitiligo is a significantly distressing condition and tends to be treatment‐resistant. The occurrence of new lesions on acral areas further causes greater psychological trauma. Topical tacrolimus has been widely used in the management of vitiligo and its role in preventing flares in other dermatoses such as atopic dermatitis has been well documented.

Objectives

To assess the role of topical tacrolimus as preventive therapy in unstable acral vitiligo. Materials and Methods In this single‐centre randomized prospective study, 60 patients aged 16–60 years having unstable acral vitiligo with symmetrical lesions were enrolled and randomized (1:1) into two groups. Patients in group A were instructed to apply topical tacrolimus 0.1% ointment on both vitiliginous and normal skin while patients in group B were instructed to apply topical tacrolimus 0.1% ointment only on vitiliginous skin for 6 months. Only the distal hand till the wrist joint was chosen for observation. Vitiliginous patches were assessed monthly for 6 months for a change in the number of lesions and total area involved, extension of preexisting lesions and adverse effects if any.

Results

A reduction in the number of lesions was observed in both groups. The decrease in the number of lesions in group A was 5.6% as compared to 2.3% in group B ( p ‐0.001). The decrease in depigmented area in group A was 10.5% as compared to 4.6% in group B ( p ‐0.048). Treatment failure was seen in 11 out of 60 (18.3%) patients.

Conclusion

Tacrolimus 0.1% ointment application showed effectiveness in preventing the appearance of new lesions in unstable acral vitiligo and hastening the repigmentation when applied on both lesional and perilesional skin in vitiligo.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TacrolimusVitiligoHumansImmunosuppressive AgentsProspective StudiesOintmentsTreatment Outcome

Substanzen

TacrolimusImmunosuppressive AgentsOintments

Autor:innen und Institutionen

  • Department of Dermatology, Venereology, and Leprology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

ORCID-Profile: Vishal Thakur, Kiruthika Subburaj, Anuradha Bishnoi, Keshavamurthy Vinay, Muthu Sendhil Kumaran, Davinder Parsad

Zitieren

APA

Kumar, D., Thakur, V., Subburaj, K., Bishnoi, A., Vinay, K., Sendhil Kumaran, M., & Parsad, D. (2023). A randomized prospective study to assess the role of topical tacrolimus as preventive therapy in unstable acral vitiligo. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.19362

Vancouver

Kumar D, Thakur V, Subburaj K, Bishnoi A, Vinay K, Sendhil Kumaran M, et al. A randomized prospective study to assess the role of topical tacrolimus as preventive therapy in unstable acral vitiligo. Journal of the European Academy of Dermatology and Venereology. 2023. doi:10.1111/jdv.19362

BibTeX
@article{Kumar2023,
  author = {Kumar, Deepak and Thakur, Vishal and Subburaj, Kiruthika and Bishnoi, Anuradha and Vinay, Keshavamurthy and Sendhil Kumaran, Muthu and Parsad, Davinder},
  title = {A randomized prospective study to assess the role of topical tacrolimus as preventive therapy in unstable acral vitiligo},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2023},
  doi = {10.1111/jdv.19362}
}
Kostenlos starten →